Alwis Group
↗Milton Keynes, United Kingdom
Alwis Group is a technology provider focused on the life sciences sector, specifically developing AI, NLP, and machine learning-based tools to revolutionize drug safety monitoring, pharmacovigilance, and regulatory compliance. Their platform suite is designed to assist medical researchers and safety professionals in managing complex regulatory landscapes, literature surveillance, and adverse event detection.
The company operates as a niche technology player, offering specialized software products such as ReTrans Enterprise, ZiCapPro, and ZiNex. They position themselves as a partner for pharmaceutical, biotechnology, and medical device companies looking to modernize their safety operations, improve operational efficiency, and ensure compliance with global regulatory standards.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Pharmacovigilance AI Software
SIZE & FINANCIALS
Employees:1-50
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Unfunded
Total Raised:$0
0
CORPORATE STRUCTURE
Key Partnerships:Why Summits (Conference/Networking partner)
COMPETITION
Position:Niche Player
Competitors:Envision Pharma Group, MasterControl, MetricStream, Vitrana
LEADERSHIP
Key Executives:
Abdul Rahim - Founder & Director
Ghalib Shariff - COO
LINKS
Website:alwisgroup.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Alwis Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Alwis Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.